(Q34708772)

4 August 2017

1 reference

title

Complete response of metastasized adrenal cortical carcinoma with o,p'-DDD. Case report and literature review (English)

1 reference

4 August 2017

Complete response of metastasized adrenal cortical carcinoma with o,p'-ddd.Case report and literature review (English)

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

7 October 2023

1 reference

1 reference

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

7 October 2023

author name string

E. Boven

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360329

7 October 2023

J. B. Vermorken

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360329

7 October 2023

H. van Slooten

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360329

7 October 2023

H. M. Pinedo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6360329

7 October 2023

language of work or name

English

0 references

publication date

1 January 1984

1 reference

full work available at URL

4 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

7 October 2023

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

7 October 2023

1 reference

4 August 2017

53

1 reference

4 August 2017

1

1 reference

4 August 2017

26-29

1 reference

o,p'DDD Therapy in Invasive Adrenocortical Carcinoma

4 August 2017

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%2819840101%2953%3A1%3C26%3A%3AAID-CNCR2820530107%3E3.0.CO%3B2-I

Adrenal cortical carcinoma. Results of treatment with o,p'DDD in 138 patients

21 January 2018

2

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

Mitotane Use in Inoperable Adrenal Cortical Carcinoma

7 October 2023

3

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

Addison's Disease Following Combined Chemotherapy for Hyperfunctioning Adrenocortical Carcinoma

7 October 2023

5

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

o,p'-DDD (mitotane) therapy of adrenal cortical carcinoma: observations on drug dosage, toxicity, and steroid replacement

7 October 2023

8

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

Natural history of adrenal cortical carcinoma: A clinicopathologic study of 42 patients

7 October 2023

10

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

Adrenal adenocarcinomas: diagnosis and management

7 October 2023

11

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

7 October 2023

Mitotane (o,p'-DDD)

12

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

Gallium Scanning in Inflammatory and Neoplastic Conditions

7 October 2023

13

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

Blood levels of o,p′-DDD following administration in various vehicles after a single dose and during long-term treatment

7 October 2023

16

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

AN EFFECT OF O,P'-DDD ON THE EXTRA-ADRENAL METABOLISM OF CORTISOL IN MAN.

7 October 2023

17

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

The effect of o,p'DDD on cortisol and hexobarbital metabolism.

7 October 2023

18

1 reference

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

https://api.crossref.org/works/10.1002/1097-0142(19840101)53:1%3C26::AID-CNCR2820530107%3E3.0.CO;2-I

7 October 2023

Identifiers

10.1002/1097-0142(19840101)53:1<26::AID-CNCR2820530107>3.0.CO;2-I

1 reference

4 August 2017

1 reference